Next Article in Journal
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Previous Article in Journal
Transplant Oncology: An Emerging Discipline of Cancer Treatment
Previous Article in Special Issue
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial
 
 
Article

Article Versions Notes

Cancers 2023, 15(22), 5338; https://doi.org/10.3390/cancers15225338
Action Date Notes Link
article xml file uploaded 9 November 2023 10:03 CET Original file -
article xml uploaded. 9 November 2023 10:03 CET Update https://www.mdpi.com/2072-6694/15/22/5338/xml
article pdf uploaded. 9 November 2023 10:03 CET Version of Record https://www.mdpi.com/2072-6694/15/22/5338/pdf
article html file updated 9 November 2023 10:04 CET Original file https://www.mdpi.com/2072-6694/15/22/5338/html
Back to TopTop